Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CCHFV nucleoprotein is central to viral replication by binding genomic RNA into protective complexes. Its unique structure supports both specific recognition of panhandle vRNA structures critical for genome packaging and broader nonspecific interactions with ss/dsRNAs. Its immunogenicity makes it valuable both diagnostically and potentially as part of future vaccines or therapeutics against this severe tick-borne disease.
Unknown, Ribavirin's efficacy remains debated
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein (NP).